165 related articles for article (PubMed ID: 23883141)
1. Severe recurrent rhabdomyolysis-induced acute kidney injury in a HIV-infected patient on antiretroviral therapy.
Spiegel LR; Schrier PB; Shah HH
Ren Fail; 2013 Sep; 35(8):1186-90. PubMed ID: 23883141
[TBL] [Abstract][Full Text] [Related]
2. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
[TBL] [Abstract][Full Text] [Related]
3. Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.
Bedimo RJ; Westfall AO; Drechsler H; Vidiella G; Tebas P
Clin Infect Dis; 2011 Jul; 53(1):84-91. PubMed ID: 21653308
[TBL] [Abstract][Full Text] [Related]
4. Proximal renal tubular dysfunction related to antiretroviral therapy among HIV-infected patients in an HIV clinic in Mexico.
Andrade-Fuentes K; Mata-Marín JA; López-De León JI; Manjarrez-Téllez B; Ramírez JL; Gaytan-Martínez J
AIDS Patient Care STDS; 2015 Apr; 29(4):181-5. PubMed ID: 25101526
[TBL] [Abstract][Full Text] [Related]
5. Rhabdomyolysis in an HIV-infected patient on anti-retroviral therapy precipitated by high-dose pravastatin.
Mikhail N; Iskander E; Cope D
Curr Drug Saf; 2009 May; 4(2):121-2. PubMed ID: 19442105
[TBL] [Abstract][Full Text] [Related]
6. Early markers of tubular dysfunction in antiretroviral-experienced HIV-infected patients treated with tenofovir versus abacavir.
Maggi P; Montinaro V; Bellacosa C; Pietanza S; Volpe A; Graziano G; Strippoli GF; Angarano G
AIDS Patient Care STDS; 2012 Jan; 26(1):5-11. PubMed ID: 22136504
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.
Herlitz LC; Mohan S; Stokes MB; Radhakrishnan J; D'Agati VD; Markowitz GS
Kidney Int; 2010 Dec; 78(11):1171-7. PubMed ID: 20811330
[TBL] [Abstract][Full Text] [Related]
8. Severe acute renal failure in an HIV-infected patient after only 2 weeks of tenofovir-based antiretroviral therapy.
Pavie J; Scemla A; Bouldouyre MA; Pillebout E; Verine J; Molina JM
AIDS Patient Care STDS; 2011 Aug; 25(8):457-60. PubMed ID: 21751874
[TBL] [Abstract][Full Text] [Related]
9. Acute tubular necrosis in a patient receiving tenofovir.
Lee JC; Marosok RD
AIDS; 2003 Nov; 17(17):2543-4. PubMed ID: 14600530
[No Abstract] [Full Text] [Related]
10. Tenofovir disoproxil fumarate-associated nephrotoxicity in HIV-infected patients: a prospective controlled study.
Woratanarat K; Kanjanabuch T; Suankratay C
J Med Assoc Thai; 2013 Apr; 96(4):432-9. PubMed ID: 23691697
[TBL] [Abstract][Full Text] [Related]
11. Renal toxicity of long-term therapy with tenofovir in HIV-infected patients.
Monteagudo-Chu MO; Chang MH; Fung HB; Bräu N
J Pharm Pract; 2012 Oct; 25(5):552-9. PubMed ID: 22551561
[TBL] [Abstract][Full Text] [Related]
12. Nephrolithiasis and hydronephrosis in an HIV-infected man receiving tenofovir.
Cicconi P; Bongiovanni M; Melzi S; Tordato F; d'Arminio Monforte A; Bini T
Int J Antimicrob Agents; 2004 Sep; 24(3):284-5. PubMed ID: 15325433
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.
Smith KY; Patel P; Fine D; Bellos N; Sloan L; Lackey P; Kumar PN; Sutherland-Phillips DH; Vavro C; Yau L; Wannamaker P; Shaefer MS;
AIDS; 2009 Jul; 23(12):1547-56. PubMed ID: 19542866
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
Leeansyah E; Cameron PU; Solomon A; Tennakoon S; Velayudham P; Gouillou M; Spelman T; Hearps A; Fairley C; Smit de V; Pierce AB; Armishaw J; Crowe SM; Cooper DA; Koelsch KK; Liu JP; Chuah J; Lewin SR
J Infect Dis; 2013 Apr; 207(7):1157-65. PubMed ID: 23303810
[TBL] [Abstract][Full Text] [Related]
15. EU issues warning about HAART regimen.
AIDS Patient Care STDS; 2004 Jan; 18(1):56-7. PubMed ID: 15080094
[No Abstract] [Full Text] [Related]
16. Acute kidney injury as a presentation of primary renal diffuse large B-cell lymphoma in HIV.
Hughes DJ; Fitzgerald N; Sran H; Konig M; Moore-Moffatt R; Webb A; Gilleece Y; Churchill DR
Int J STD AIDS; 2014 Apr; 25(5):380-2. PubMed ID: 24047882
[TBL] [Abstract][Full Text] [Related]
17. Tenofovir-induced renal toxicity in 324 HIV-infected, antiretroviral-naïve patients.
Calza L; Trapani F; Tedeschi S; Piergentili B; Manfredi R; Colangeli V; Viale P
Scand J Infect Dis; 2011 Aug; 43(8):656-60. PubMed ID: 21453205
[TBL] [Abstract][Full Text] [Related]
18. Tenofovir-induced kidney disease: an acquired renal tubular mitochondriopathy.
Perazella MA
Kidney Int; 2010 Dec; 78(11):1060-3. PubMed ID: 21076445
[TBL] [Abstract][Full Text] [Related]
19. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.
Gulick RM; Lalama CM; Ribaudo HJ; Shikuma CM; Schackman BR; Schouten J; Squires KE; Koletar SL; Pilcher CD; Reichman RC; Klingman KL; Kuritzkes DR
AIDS; 2007 Apr; 21(7):813-23. PubMed ID: 17415036
[TBL] [Abstract][Full Text] [Related]
20. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
Bayonne Kombo ES; Gathse A
Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
[No Abstract] [Full Text] [Related]
[Next] [New Search]